SANGAMO THERAPEUTICS, INC (36) | Business Operations (6)

Browse by Subcategory

Collaboration Agreements (6)

Recent Contracts

Amendment No. 2 to Research Collaboration and License Agreement between the Company and Pfizer Inc., dated July 21, 2020 (Filed With SEC on November 4, 2020)
Collaboration and License (Filed With SEC on November 4, 2020)
Collaboration and License Agreement among the Company, Biogen MA, Inc. and Biogen International GmbH, dated February 26, 2020 (Filed With SEC on May 11, 2020)
Letter Amendment, dated December 17, 2019, to the Collaboration and License Agreement between the Company and Pfizer Inc., dated May 10, 2017 (Filed With SEC on February 28, 2020)
Amended and Restated Collaboration and License Agreement between the Company and Kite Pharma, Inc., dated as of September 11, 2019 (Filed With SEC on November 6, 2019)
Amendment No. 1 to Research Collaboration and License Agreement between the Company and Pfizer., dated December 27, 2017, dated as of March 21, 2019 (Filed With SEC on May 8, 2019)